Acute Coronary Syndrome

More documents

Recommendations

Info

Early Risk Stratification I IIa IIb III A rapid clinical determination of the likelihood risk of obstructive CAD (i.e., high, intermediate, or low) should be made in all patients with chest discomfort or other symptoms suggestive of an ACS and considered in patient management. I IIa IIb III Patients who present with chest discomfort or other ischemic symptoms should undergo early risk stratification for the risk of cardiovascular events (e.g., death or [re]MI) that focuses on history, including anginal symptoms, physical findings, ECG findings, gs,a and dbo biomarkers so of cardiac dac injury, and results should be considered in patient management.
Early Risk Stratification I IIa IIb III Patients with negative cardiac biomarkers within 6 h of the onset of symptoms consistent t with ACS should have biomarkers remeasured in the time frame of 8 to 12 h after symptom onset. (The exact timing of serum marker measurement should take into account the uncertainties often present with the exact timing of onset of pain and the sensitivity, precision, and institutional norms of the assay being utilized as well as the release kinetics of the marker being measured.) I IIa IIb III The initial evaluation of the patient with suspected ACS should include the consideration of noncoronary causes for the development of unexplained symptoms.
Page 1: Acute Coronary Syndrome: Thoughts o
Page 4 and 5: Case 1 • Exam: • 142/74, HR 88,
Page 6 and 7: Case 1 • Arrival to ED: • ECG
Page 8: Case 1 • Decision made to pursue
Page 12: Evidence Based Data
Page 15 and 16: Variables Used in the TIMI Risk Sco
Page 17 and 18: I IIa IIb III Updated Guidelines Cl
Page 19 and 20: Initial Chest Pain Evaluation Sympt
Page 24 and 25: Lipid Management I IIa IIb III I I
Page 26 and 27: Pravastatin Or atorVastatin Evaluat
Page 28 and 29: Diabetes Mellitus I I I IIa IIb III
Page 30 and 31: Weight Management I IIa IIb III New
Page 32 and 33: Depression I IIa IIb III It is reas
Page 36 and 37: Timing of Release of Various Biomar
Page 38 and 39: Immediate Management I IIa IIb III
Page 40 and 41: Anti-Ischemic Therapy I IIa IIb III
Page 42 and 43: Antiplatelet Therapy I IIa IIb III
Page 44 and 45: Initial Conservative Versus Initial
Page 50 and 51: I IIa IIb III Hospital Care Conserv
Page 52 and 53: Risk Factor Modification I IIa IIb

Acute Coronary Syndrome

Create successful ePaper yourself

Delete template?

Save as template?